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1. Introduction
This report provides an overview of the currently available quantitative information about osteoporosis
in the Netherlands, and of the cost associated with it. We present information relevant for this country,
making as few assumptions as possible. When assumptions are made, they are clearly stated in the text.
Although the main subject is osteoporosis, the focus in this report is on fractures, as these are the most
relevant outcome events of this condition.
The data were collected from publicly available data sources and from international literature.
Information is mostly about the year 1993, but sometimes we are forced to use information from other
years. No primary data collection has been carried out.
The reader finds detailed information about the occurrence of osteoporosis and fractures, the utilisation
of health care, mortality, and the costs in the results' section of this report. In the conclusions, we
present a synthesis of the most important findings.
2. Background and rationale
Osteoporosis is, by consensus, defined as a systemic skeletal disease, characterised by low bone mass
and microarchitectural deterioration of bone tissue with a consequent increase in bone fragility and
susceptibility to fracture.1 There is an important age-related decrease in bone mass and bone strength.
Osteoporosis is primarily described in post-menopausal women but men are not free from it; they also
reach high fracture incidence rates at an older age. Combined with the longer survival of women, this
leads to the observation that most osteoporotic fractures are encountered in females.
Osteoporosis and its direct consequences, fractures, are a major concern for public health, as they are
responsible for death and for substantial disability. Moreover, they represent an important cost for the
public health budget. In the US, it was estimated that osteoporotic fractures cost US$ 7 - 10 billion each
year, and that this cost will inevitably rise as the population continues to age.2
Osteoporosis, defined as a reduction in bone mass below a specified threshold, has been shown to be a
major determinant of fracture risk.3 Bone mass can be measured with sufficient accuracy and precision,
so that it is nowadays the best readily available indicator of fracture risk, other than age and sex. There
is however a considerable overlap of bone density values between people who develop fractures and
people who do not.
Bone mineral density (BMD) is however not the only element involved in fractures. There is of course
the trauma, that is the direct cause of the fracture. Propensity to fall increases with age due to
disturbances of equilibrium, decrease in mobility, dementia, cardiovascular morbidity, etc. The impact
of those, non bone density related factors, is commonly measured by using age as a surrogate for
predicting fractures. Bone strength is not only determined by bone mass, but also dependent upon the
properties of the bone tissue and upon its spatial arrangement. This is often referred to as bone quality.
It has been suggested that the relative contributions of bone mass, bone quality, and trauma to the
aetiology of fractures might be different for different parts of the skeleton.2
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3. Data sources
In each of the following chapters the data sources used are mentioned. Here, a general description of the
data sources is given. Were possible, data for 1993 (the 'reference year') are used. Where this is not
possible, it is clearly indicated in the text.
3.1. Central Bureau for Statistics (CBS)
The CBS (Centraal Bureau voor de Statistiek) is the official Dutch organisation that covers the national
registration of a wide variety of statistics, including demography, registration of causes of death, etc.
Some of this information is published in yearly and monthly publications. Other information, such as
causes of death related to osteoporosis was specifically obtained for this study.
3.2. Foundation for Health Care Information (SIG)
The SIG (Stichting Informatiecentrum voor de Gezondheidszorg) is a national registry collecting
various health care related data. All of the hospitalisations in academic and general hospitals within the
Netherlands are included in this registration as is most of the nursing home information. Both published
information and files specifically obtained for the purpose of this study are used in this report.
3.3. Institute for Medical Statistics (IMS)
IMS is a company that collects data on health care by sampling GP's and specialists. These data provide
an indication about the patient contacts they had within a given week. The reason for encounter,
diagnosis, patient demographics, and therapy is recorded. Furthermore, data from pharmacies are
sampled to calculate the actual sales of drugs. In the latter registration, no medical indication is
recorded.
3.4. Home Health Care Service Rotterdam
The Home Health Care Service Rotterdam (Thuiszorg Rotterdam) collects information on all home
health care activities in the city of Rotterdam. This registration is used to estimate the use of home
health care in the Netherlands.
3.5. Literature
An effort is made to use information directly relevant for the Netherlands. Where specific data for the
Netherlands are lacking, international data were used, and this is clearly indicated in the text.
3.6. Expert opinion
Where available data needed more explanation and clinical common sense was required, expert opinion
was obtained from specialists at the Rotterdam Academic Hospital.
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4. Results
4.1. Evaluation of the prevalence of osteoporosis
Age and sex distribution of the population
Demographic trends
As in most Western countries, the population of the Netherlands is ageing. The size of the population
increased from 10 million to 15 million in the period 1950-1990 mainly due to the post-war baby boom.
At the same time there was a gradual increase in the proportion of old people. Over the next decades
this latter trend will continue. The Dutch population is primarily white Caucasian, and the incidence of
osteoporosis is known to be different in other races. No ethnic specific information about osteoporosis
is available for the Netherlands. The Netherlands Central Bureau of Statistics (CBS) produces on a
regular basis forecasts to predict the future composition of the population. Those forecasts are known as
the high, medium and low variant, but their basic assumption is that there are no drastic changes in
neither behaviour, policy, (medical) technology and that there are no major catastrophes. It is what is
called a surprise-free forecast. The forecasts are based on the trends from the near past. The CBS
forecasts are updated each year, on the basis of the latest developments. For this report, we use the
1994-2050 forecast.4
The Dutch population by age and sex in 1993
Age and sex distribution on January 1, 19935
Age class Men Women Total
0-4 497136 474951 972087
5-9 466268 446458 912726
10-14 463287 442961 906248
15-19 487831 467578 955409
20-24 634632 612174 1246806
25-29 671772 636212 1307984
30-34 652018 624608 1276626
35-39 602068 581178 1183246
40-44 589866 564605 1154471
45-49 556623 530227 1086850
50-54 422624 406733 829357
55-59 364725 365343 730068
60-64 333548 358229 691777
65-69 283457 337536 620993
70-74 222178 298242 520420
75-79 148868 238855 387723
80-84 86591 176009 262600
≥85 51776 142015 193791
Total 7535268 7703914 15239182
Age and sex distribution on January 1, 1993 (grouped by broader age classes)
Age class Men Women Total
0-44 5064878 4850725 9915603
45-54 979247 936960 1916207
55-64 698273 723572 1421845
65-74 505635 635778 1141413
75-84 235459 414864 650323
≥85 51776 142015 193791
Total 7535268 7703914 15239182
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Population forecast
Different variants are published. The medium variant is the most likely development. In the low variant
birth rates as well as immigration and divorce rates are lower, while mortality, emigration and marriage
rates are higher. The opposite is done in the high variant.
In the elderly population of interest in this report, the differences between the several variants are
relatively small in the coming decades. Those persons are born already, and only mortality and
migration will influence their numbers. As an illustration the age specific population forecast for 2030
is shown with the low, medium and high variant.
Age specific population forecast 2030 (x1000)
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The data shown in the next table are the medium variant of the forecast. Those data show a slight
increase of the total population until around the year 2035 when a maximum of 17.5 million Dutch will
be reached. Thereafter a slight decrease of the total population is predicted.
Census projection, medium variant (x1000)
Prediction 2000 Prediction 2010
Age class Men Women Total Age class Men Women Total
0-19 2008 1914 3922 0-19 2083 1976 4059
20-39 2457 2341 4798 20-39 2176 2056 4232
40-59 2220 2153 4373 40-59 2515 2440 4955
60-79 1088 1298 2386 60-79 1403 1546 2949
≥80 151 352 503 ≥80 195 420 615
Total 7924 8058 15982 Total 8372 8438 16810
Prediction 2020 Prediction 2030
Age class Men Women Total Age class Men Women Total
0-19 1978 1874 3852 0-19 1972 1869 3841
20-39 2222 2082 4304 20-39 2297 2144 4441
40-59 2460 2366 4826 40-59 2187 2088 4275
60-79 1719 1891 3610 60-79 1942 2136 4078
≥80 229 449 678 ≥80 322 590 912
Total 8608 8662 17270 Total 8720 8827 17547
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Prediction 2040 Prediction 2050
Age class Men Women Total Age class Men Women Total
0-19 2021 1915 3936 0-19 1958 1856 3814
20-39 2192 2042 4234 20-39 2186 2036 4222
40-59 2238 2115 4353 40-59 2308 2175 4483
60-79 1856 2051 3907 60-79 1655 1814 3469
≥80 363 687 1050 ≥80 406 759 1165
Total 8670 8810 17480 Total 8513 8640 17153
Age and sex distribution of the population meeting BMD definition of
osteoporosis
The BMD reference data for the Netherlands come from a cross-sectional, population based study,
where baseline BMD measurements were performed in 1762 ambulatory subjects (678 men and 1084
women) aged 55 years and more.6 This study is part of the Rotterdam study, a prospective follow-up
study of the occurrence and determinants of disease and disability in the elderly7 that also will provide,
over time, follow-up data on BMD evolution and fractures.
For densitometry, institutionalised persons (10%) were not eligible in this study. Densitometry was
performed using dual energy X-ray absorptiometry (DXA) of the lumbar spine and proximal femur
(femoral neck, Ward's triangle and trochanter). BMD measurements were performed using a Lunar
DPX-L densitometer (Lunar Radiation Corporation, Madison, WI).
Men
Age class Neck g/cm2
(SD)
Ward g/cm2
(SD)
Trochanter g/cm2
(SD)
L2-L4 g/cm2
(SD)
55-59 0.912 (0.108) 0.771 (0.129) 0.882 (0.115) 1.138 (0.193)
60-64 0.917 (0.124) 0.755 (0.143) 0.883 (0.122) 1.179 (0.186)
65-69 0.880 (0.131) 0.713 (0.157) 0.836 (0.150) 1.140 (0.203)
70-74 0.876 (0.142) 0.705 (0.154) 0.836 (0.139) 1.171 (0.213)
75-79 0.874 (0.140) 0.708 (0.156) 0.835 (0.138) 1.165 (0.214)
80-84 0.852 (0.157) 0.690 (0.193) 0.828 (0.167) 1.193 (0.249)
≥85 0.835 (0.147) 0.675 (0.172) 0.838 (0.191) 1.344 (0.278)
Total 0.886 (0.134) 0.724 (0.156) 0.851 (0.140) 1.166 (0.211)
Adjusteda 0.892 (0.121) 0.730 (0.139) 0.860 (0.122) 1.176 (0.183)
Women
Age class Neck g/cm2
(SD)
Ward g/cm2
(SD)
Trochanter g/cm2
(SD)
L2-L4 g/cm2
(SD)
55-59 0.877 (0.131) 0.749 (0.150) 0.758 (0.128) 1.062 (0.141)
60-64 0.840 (0.120) 0.695 (0.144) 0.746 (0.128) 1.007 (0.174)
65-69 0.826 (0.128) 0.680 (0.143) 0.735 (0.128) 1.042 (0.184)
70-74 0.811 (0.124) 0.668 (0.141) 0.734 (0.131) 1.040 (0.183)
75-79 0.766 (0.132) 0.615 (0.143) 0.694 (0.144) 0.996 (0.193)
80-84 0.760 (0.110) 0.613 (0.127) 0.696 (0.152) 1.038 (0.201)
≥85 0.730 (0.125) 0.580 (0.145) 0.655 (0.140) 1.077 (0.224)
Total 0.814 (0.131) 0.670 (0.149) 0.727 (0.136) 1.032 (0.183)
Adjusteda 0.812 (0.120) 0.664 (0.139) 0.720 (0.122) 1.026 (0.183)
a Adjusted for age and body mass index.
Osteoporosis in the Netherlands
7
BMD measurements for the femoral neck in men and women (g/cm2)
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The main conclusion from this cross-sectional study is that the apparent rate of bone loss is significantly
different between men and women at all femoral sites. The rate of decline of the BMD in women at the
femoral neck is almost twice as high as that in men. The observed absolute rates of decline in the
proximal femur of women are equal to the results of the Framingham Osteoporosis Study.8 It is also
observed that the mean bone reduction due to early menopause is relatively small compared to the
effect of age. In this study, it is estimated that 1 year of age-related bone reduction in the Ward's
triangle could be compensated by a 3 year later onset of menopause. This last finding seems to be
contradicted in another study on BMD and age in Dutch women by Erdtsieck et al.9 From this relatively
small and highly selected group of 260 healthy women aged 20-80 they conclude that a 1 year later
onset of the menopause compensates for 2 years of age-related BMD loss.
At the lumbar spine no significant age-related decrease in BMD is found. It is suggested that this could
be explained by age-related local factors such as the presence of marked spinal osteoarthritis in the
region of interest.
Finally, caution is expressed for the fact that this study concerns cross-sectional data, and that the
results may have been influenced by age-dependent selection and also by cohort effects.
Age and sex-specific incidence of fractures
Hip fractures
In the Netherlands, virtually all persons with hip fractures are treated clinically. Therefore, it is felt that
hospital data give an accurate view of the incidence of hip fractures.
Data for hip fractures in 1993 were collected from SIG hospital registration data as described in the
chapter on data sources. A specific file of all hospital admissions for hip fracture was obtained and
analysed. Trend data since 1972 are collected from literature,10 and are based on the same (SIG)
hospital registration source.
To make the comparison with available trend data possible, a first analysis was made including all
patients with hospital admission due to hip fracture (ICD-9 code 820xx). In the subsequent analysis,
patients with codes for high energy trauma or cancer were omitted, as specified in the MSD study
protocol.
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Absolute numbers of hip fractures in 1993
Age class Men Women Total
0-4 14 15 29
5-9 13 5 18
10-14 27 17 44
15-19 32 5 37
20-24 38 9 47
25-29 48 9 57
30-34 46 10 56
35-39 50 22 72
40-44 84 34 118
45-49 123 72 195
50-54 100 125 225
55-59 149 194 343
60-64 203 385 588
65-69 307 702 1009
70-74 470 1256 1726
75-79 649 1862 2511
80-84 689 2532 3221
≥85 840 3971 4811
Total 3882 11225 15107
Age and sex-specific hip fracture incidence in 1993
The absolute numbers of fractures were combined with the age and sex distribution of the 1993 Dutch
population to estimate the hip fracture incidences.
In the next table, the incidences per 100.000 person years are given in the standard CBS 5 year age
classes. The figure additionally displays the incidences of 85-89, 90-94 and ≥ 95. At those ages, hip
fracture incidences become very high.
Age class Men Women
0-4 2.82 3.16
5-9 2.79 1.12
10-14 5.83 3.84
15-19 6.56 1.07
20-24 5.99 1.47
25-29 7.15 1.41
30-34 7.06 1.60
35-39 8.30 3.79
40-44 14.24 6.02
45-49 22.10 13.58
50-54 23.66 30.73
55-59 40.85 53.10
60-64 60.86 107.47
65-69 108.31 207.98
70-74 211.54 421.13
75-79 435.96 779.55
80-84 795.69 1438.56
≥85 1622.37 2796.18
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Hip fracture incidence in the Netherlands in 1993 per 100.000
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1993 Hip fracture incidence (per 100.000) in the broader age classes
Age class Men Women
0-44 6.95 2.60
45-54 22.77 21.03
55-64 50.41 80.02
65-74 153.67 307.97
75-84 568.25 1059.14
≥85 1622.37 2796.18
Trend data
Trend data from 1972 till 1987 for the Netherlands are published for men and women aged 50 years and
older.10 Hip fracture incidence was age-adjusted by direct standardisation. To be able to compare the
1993 data with the published data, we obtain the standard population for the standardisation in the same
way as in the study by Boereboom et al (summation of the Dutch population for the calendar years
1972-1987). When we add the 1993 data to the previous analysis the significant upward trend that is
described previously is confirmed. In women, age standardised hip fracture incidence that increased
from 249/100.000 in 1972 to 345/100.000 in 1987 reached 371/100.000 in 1993. For men, the increase
was from 105/100.000 in 1972 over 150/100.000 in 1978 to 168/100.000 in 1993. This trend is highly
significant in both men and women (p<0.001). The strange peak in the 1979 data remains unexplained.
A data artefact in that year may have occurred.
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Trend in age-adjusted hip fracture incidence in the Netherlands in men and women aged 50 years and
older (incidence/100.000)
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Effect of demography on hip fractures
Apart from this important age-adjusted upward trend, the total number of hip fractures in the
Netherlands in the next decades will also increase due to the demographic changes with the ageing of
the population. If the current age specific hip fracture rates are applied to the population forecast
figures, the total number of hip fractures will double by the year 2050 due to demography alone.
Yearly predicted number of hip fractures in the Netherlands due to demographic changes
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Yearly predicted number of hip fractures in the Netherlands due to demographic changes by sex
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1993 hip fractures, excluding trauma or cancer
When applying the exclusion criteria from the MSD Study Protocol, only a few of the total hip fracture
cases have to be excluded:
Elimination  of old fractures or non-osteoporotic fractures
ICD 9-CM Description Number
733.42 Aseptic Necrosis of head and neck of femur 8
733.81-733.82 Non-union of fractures 12
198.5 Sec. malignant neoplasm of bone and bone marrow 22
199.0 Disseminated malignant neoplasm 9
199.1 Cancer, site unspecified 7
733.1 Pathologic fracture 8
Total 66
Total potential exclusions (a few double exclusions) 64
733.0x Osteoporosis (not to be excluded) - 3
Number of exclusions 61
After excluding those cases, the age-adjusted incidences barely change. It is however uncertain whether
the registration of secondary diagnosis is as accurate as that of primary diagnosis. These exclusions
might thus be underestimated.
1993 Hip fracture incidence (per 100.000) in broader age classes after exclusions
Age class Men Women
0-44 6.91 2.60
45-54 22.77 20.71
55-64 50.27 79.61
65-74 153.07 307.03
75-84 563.58 1055.29
≥85 1604.99 2791.25
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Absolute numbers of hip fractures after exclusions
Age class Men Women Total
0-4 14 15 29
5-9 13 5 18
10-14 27 17 44
15-19 31 5 36
20-24 38 9 47
25-29 47 9 56
30-34 46 10 56
35-39 50 22 72
40-44 84 34 118
45-49 123 71 194
50-54 100 123 223
55-59 149 192 341
60-64 202 384 586
65-69 306 701 1007
70-74 468 1251 1719
75-79 644 1855 2499
80-84 683 2523 3206
≥85 831 3964 4795
Total 3856 11190 15046
In the analyses hereafter, the above numbers, after exclusions, will be used.
Non-hip fractures
Dutch data for non-hip fractures
Although hip fractures are the most serious consequences of osteoporosis, other fractures do occur.
Those are mainly fractures of the vertebrae and the forearm. Most frequently, those fractures do not
require a hospital admission and are treated either in the outpatient clinic or, in the case of vertebral
fractures, often not treated at all. When looking at the hospital admissions for fractures other than the
hip, we observe smaller numbers and also the absence of the typically high percentage of persons over
65 years of age. We equally do not observe the typically high female/male ratio of fractures. Therefore,
it seems that the hospitalisation data are not reflecting the osteoporosis related fractures, and that they
cannot be used to estimate the incidence of osteoporosis related non-hip fractures.
Hospital admissions for vertebral and forearm fractures in the Netherlands in 199211
Total ≥65 years ≥65 year (%) female/male ratio
Vertebrae 2586 977 37.8% 1.1
Forearm 4180 902 21.6% 1.0
Hip 14467 12583 87.0% 2.8
No data are available yet for osteoporosis related non-hip fractures in the Netherlands. In the absence of
those data, data from the international literature are taken. In the future, incidence data for fractures in
the Netherlands will be available from the Rotterdam study.
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International data for non-hip fractures
Melton et al., in an 1992 overview article,12 present the following incidence figures for men and women
in Rochester, Minnesota. Those data should be used with caution since the incidences refer to different
time periods and the vertebral fractures only refer to clinically diagnosed fractures. We choose to use
clinically diagnosed vertebral fractures, since there is some debate about the definition of radiographic
vertebral deformities. Different techniques of measurement and different criteria can produce varying
results and varying fracture rates. On the other hand, clinically diagnosed vertebral fractures are more
directly relevant to the cost. These incidence rates appear to be the best available estimate.
First fracture incidence rates per 100.000 person-years in men
Men Hip Vertebrae Forearm
50-54 12.5 58.6 118.4
55-59 36.9 82.4 92.9
60-64 58.0 40.8 74.3
65-69 139.7 143.2 113.3
70-74 241.7 154.8 90.6
75-79 423.2 466.1 111.8
80-84 850.6 421.0 78.3
≥85 1719.5 1326.7 78.3
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First fracture incidence rates per 100.000 person-years in women
Women Hip Vertebrae Forearm
50-54 69.5 123.0 355.4
55-59 135.4 248.2 494.9
60-64 169.6 283.3 639.8
65-69 314.2 463.5 567.6
70-74 493.5 634.0 669.8
75-79 1033.2 938.7 517.8
80-84 1669.3 1224.2 526.9
≥85 2552.5 1213.5 699.2
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Extrapolation of international data to Dutch non-hip fractures
When comparing the Rochester incidences of hip fractures with the ones for the Netherlands in 1993,
they appear to be remarkably similar.
Age specific hip fracture incidence in men.
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Age specific hip fracture incidence in women.
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Since the incidence rates of hip fractures are very comparable, we assume we can also use the Rochester
data to estimate the number of non-hip fractures in the Netherlands, although we are aware that time
trends and incidences might be different. The upward time trend in the hip fracture incidence for
example appears to have stopped in several countries, including the US.13
Estimated yearly number of (first) non-hip fractures in the Netherlands in men
Age class Vertebrae Forearm
50-54 248 500
55-59 301 339
60-64 136 248
65-69 406 321
70-74 344 201
75-79 694 166
80-84 365 68
≥85 687 41
Total 3181 1884
Estimated yearly number of (first) non-hip fractures in the Netherlands in women
Age class Vertebrae Forearm
50-54 500 1446
55-59 907 1808
60-64 1015 2292
65-69 1564 1916
70-74 1891 1998
75-79 2242 1237
80-84 2155 927
≥85 1723 993
Total 11997 12617
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4.2. Evaluation of the health care utilisation associated with osteoporosis
Pharmacotherapy
The use of drugs in the treatment or prevention of osteoporosis is estimated based on IMS data. The
total figures are adjusted for the estimated proportion of the drug that is used for osteoporosis.
Presentation and dosage can differ from one prescription to another. Therefore, date are recalculated to
estimate patient-years of treatment for the leading products.
Patient years in 1993 for the leading osteoporosis products in the Netherlands ( x 1000)
1993
patient years
Share
Didrokit 18.6 30.7%
Calcium Forte 11.7 19.3%
Calcium Fortissimum 5.8 9.6%
Cacit 500 5.0 8.3%
Etalpha 0.9 1.5%
Didronel 0.2 0.3%
Progynova 1.2 2.0%
Decadurabolin 0.4 0.7%
Devaron 5.3 8.8%
Premarin 0.3 0.5%
Procal 0.5 0.8%
Zumenon 0.2 0.3%
Estraderm TTS 1.3 2.2%
Dohyfral AD 3 9.1 15.0%
Calc. gluc-2 0.0 0.0%
Calcii lactas-2 0.0 0.0%
Total 60.6 100.0%
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Hospitalisations
Hip fractures
Hospitalisation data are collected from the SIG hospital registration data. We use the same file of
hospital admissions as used for the estimation of hip fracture incidence.
Age and sex specific length of stay (days) after hip fractures
The mean length of stay (LOS) is 26.03 days, with a standard deviation of 29 days. The distribution of
the LOS is highly skewed and an association with age and sex is observed. Mean LOS in men is 23.7;
mean LOS in women is 26.8 (p<0.001). Median LOS is 16 days for men and 19 days for women.
Age and sex specific mean length of stay (days)
Age class Men Women Total
0-4 32.6 19.6 30.6
5-9 31.8 19.2 28.3
10-14 16.7 10.1 14.1
15-19 14.4 19.4 15.1
20-24 14.8 10.8 14.0
25-29 13.0 12.3 12.9
30-34 13.3 20.0 14.5
35-39 17.8 12.1 16.1
40-44 14.5 14.9 14.6
45-49 13.4 16.5 14.5
50-54 16.2 16.0 16.1
55-59 17.6 19.2 18.5
60-64 18.6 18.5 18.6
65-69 19.7 21.8 21.1
70-74 23.4 22.6 22.8
75-79 26.5 26.4 26.4
80-84 28.2 29.7 29.4
≥85 27.4 29.5 29.2
Length of stay in persons aged 50 and older (until 10 weeks)
Length of stay (weeks)
10.009.008.007.006.005.004.003.002.001.00
Sex
Women
Men
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Age and sex specific number of hospitalisation days
Age class Men Women Total
0-4 456 294 750
5-9 414 96 510
10-14 450 172 622
15-19 446 97 543
20-24 561 97 658
25-29 612 111 723
30-34 613 200 813
35-39 891 266 1157
40-44 1218 506 1724
45-49 1648 1173 2821
50-54 1618 1964 3582
55-59 2625 3683 6308
60-64 3759 7114 10873
65-69 6019 15275 21294
70-74 10944 28325 39269
75-79 17082 48988 66070
80-84 19248 74932 94180
≥85 22809 116983 139792
Total 91413 300276 391689
Discharge status after hospitalisation
Absolute numbers
Discharge status Men Women Total
home 2510 6643 9153
elderly home 153 840 993
nursing home 799 3044 3843
died in hospital 391 660 1051
left (own decision) 3 3 6
Total 3856 11190 15046
Percentages
Discharge status Men Women Total
home 65.1% 59.4% 60.8%
elderly home 4.0% 7.5% 6.6%
nursing home 20.7% 27.2% 25.5%
died in hospital 10.1% 5.9% 7.0%
left (own decision) 0.1% 0.0% 0.0%
After the acute episode, women go more often to a home for the elderly or to a nursing home than men,
but in men the crude in-hospital mortality is almost twice that of women. The trends in discharge status
are also strongly age dependent as can be seen in the next two figures.
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Discharge status by age for men
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Discharge status by age for women
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Non-hip fractures
With respect to non-hip fractures, only the data for 1992 are readily available. As mentioned before, we
need to be cautious while interpreting those data. These hospitalisations do not seem to reflect the
typical osteoporosis related fracture pattern such as a high female/male ratio, and might be more related
with high energy trauma. Most people with those fractures are indeed treated outside the hospital. The
data are included here for the sake of completeness.
Hospital admissions for vertebral and forearm fractures in the Netherlands in 1992
Total ≥65 years ≥65 year (%) female/male ratio
Vertebrae 2586 977 37.8% 1.1
Forearm 4180 902 21.6% 1.0
Hip 14467 12583 87.0% 2.8
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Non-hospital inpatient care (full care and day care)
Data for non-hospital inpatient care are obtained from the SIG data source. Data are collected for both
full care as for day care in nursing homes. Data collection is relatively complete but less so than the
hospitalisation data. Information is available for 89.9 % of nursing homes, corresponding to 92.8 % of
the 'somatic' beds and 91.2 % of the 'psycho-geriatric' beds. Overall information is available from 92 %
of the nursing home beds.14 Patients with fractures are mainly (98%) treated in the somatic nursing
home wards. To obtain a more accurate estimate of the absolute numbers for the Netherlands, we
multiply the data from the SIG registration with a factor 1.08. For day care, the information is slightly
less complete: information is available concerning 88.7% of 'somatic' beds and 89.5% of the 'psycho-
geriatric' beds. Overall information is available from 89.1% of the day care beds. For day care
therefore, the multiplication factor used is 1.12.
In addition to the published data, files of all 1993 discharges (full care and day care) with admission
diagnosis of hip- or other fractures were obtained and analysed. A complication here is that admission
diagnosis is not coded with ICD-9 codes, but with a proprietary 'SIVIS' code. The codes that are of
interest here are
17.01 Hip fracture
17.02 Other fractures (all other fractures that are reason for admission)
19.03 Status after hip fracture
Full care
Number of discharges in 1993 with admission diagnosis
Admission diagnosis Men Women Total
Hip fracture 241 1013 1254
Other fractures 298 1091 1389
Status after hip fracture 521 2667 3188
Total 1060 4771 5831
Proportion of fracture patients vs. total population in nursing homes
When looking at the total population of people in nursing homes, the proportion of people with
admission diagnose of fracture seems to be relatively stable. Two cross-sectional views at specific days
are compared; one from our data analysis, the other from the published data.
Cross-sectional situation on December 31, 1993 (our analysis)
Total population Fractures
Age class Men Women Men Women
0-44 425 373 9 13
45-54 386 394 5 15
55-64 960 957 35 41
65-74 2730 4270 99 295
75-84 5133 14750 227 1345
≥85 3156 15195 250 1914
Total 12790 35939 625 3623
48729 4248
Percentage of total 4.9% 10.1%
population 8.7%
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Cross-sectional situation on September 30, 1992 (published data)
Admission diagnosis Total Proportion of
total population
Proportion of
all fractures
Hip fracture 1116 2.3% 26.9%
Other fractures 801 1.7% 19.3%
Status after hip fracture 2228 4.6% 53.8%
All fractures 4145 8.6% 100.0%
Hip fracture and status after 3344 6.9% 80.7%
Total population 48202 100.0%
From those data we conclude that fractures account for about 8.7 % of the population of nursing homes.
Over 80 % of these are admitted for hip fractures and its sequelae.
Applying the multiplication factor (1.08) described above, it is estimated that in 1993, respectively
4588 persons (4248*1.08) , and 3702 (4248*1.08*80.7 %) have been treated daily in nursing homes for
respectively fractures or hip-fractures and its sequelae.
It is important however to estimate the proportion of nursing home admissions that are directly related
to fractures. Some of the patients might also have been admitted without a hip fracture because of co-
morbidity, while the hip fracture event is only the precipitating factor. Therefore, we analyse length of
stay and discharge status.
Age and sex specific length of stay (days)
The average length of stay is approximately the same for both sexes: 238 (SD=553) for men and 241
(SD=553) for women (p=0.85).  Median LOS is 67 days for men and 70 days for women. The high
mean LOS and its high standard deviation are explained by the relatively large group of people that stay
extremely long (up to 21 years). It is hypothesised that those long stays in nursing homes cannot solely
be attributed to the hip-fracture but must largely be due to co-morbidity leading to a more dependent
state.
Number of patients by length of stay and admission diagnosis (full care nursing home)
0-3 months 4 months -
1 year
> 1 year Total
Men
Hip fracture 121 77 43 241
Other fractures 193 68 37 298
Status after hip fracture 329 116 76 521
Total men 643 261 156 1060
Women
Hip fracture 512 299 202 1013
Other fractures 586 352 153 1091
Status after hip fracture 1744 612 311 2667
Total women 2842 1263 666 4771
Grand Total 3485 1524 822 5831
The majority of patients are discharged within 3 months. When those people that stay up to 3 months in
the nursing home are considered separately, the average LOS are 41.6 days (SD=23.6) for men, and
44.0 days (SD=22.4) for women (p=0.02).
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Length of stay in first year (full care nursing home)
Sex
Women
Men
Number of months
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Discharge status
When looking at discharge status, we again treat those people that stay for a shorter period separately
from those that stay longer. The majority of people that stay more than one year in a nursing home, stay
there until they die (over 80 % in both men and women and for all diagnosis groups).
Those that stay for less then one year have a totally different discharge pattern. In general, about 60 %
of the people admitted to nursing home stay there for a maximum of 3 months. Over 70 % of those
return home afterwards, 8.6 % die in the nursing home (men more then women, persons with hip
fracture  more then persons with other types of fracture). The rest goes primarily to homes for the
elderly, or to a lesser degree to day care, hospital etc.
For longer stays, the discharge status changes: gradually more people are dying and less people are
going home. At 4 months LOS the percentage going home drops to 54.8 %, after 5 months to 34.6 %.
These persons with longer stays clearly represent a more dependent group of people, with more
concomitant illnesses. On the basis of the length of stay and discharge patterns, we hypothesise that
only the first few months of stay in a nursing home represent the direct effect of osteoporosis and
fractures. Therefore, we include only the first three months of stay in the nursing home in the
calculation of costs.
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Discharge patterns in first 5 months of LOS (full care nursing home)
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Discharges after 1 - 3 months (full care nursing home)
Men Women
Status Hip fr. Other fr. Post hip fr. Total Hip fr. Other fr. Post hip fr. Total
Died 24 18 52 94 89 44 111 244
Home 70 134 226 430 311 429 1365 2105
Day care 6 4 5 15 5 9 31 45
Hosp 7 24 27 58 25 23 71 119
Nursing home 3 1 1 5 10 7 12 29
Home for the elderly 11 10 18 39 71 72 151 294
Other 1 1 2
Unknown 2 2 2 2 4
Total 121 193 329 643 512 586 1744 2842
Discharges after 1 - 3 months (percentages - full care nursing home)
Men Women
Status Hip fr. Other fr. Post hip fr. Total Hip fr. Other fr. Post hip fr. Total
Died 19.8% 9.3% 15.8% 14.6% 17.4% 7.5% 6.4% 8.6%
Home 57.9% 69.4% 68.7% 66.9% 60.7% 73.2% 78.3% 74.1%
Day care 5.0% 2.1% 1.5% 2.3% 1.0% 1.5% 1.8% 1.6%
Hosp 5.8% 12.4% 8.2% 9.0% 4.9% 3.9% 4.1% 4.2%
Nursing home 2.5% 0.5% 0.3% 0.8% 2.0% 1.2% 0.7% 1.0%
Home for the elderly 9.1% 5.2% 5.5% 6.1% 13.9% 12.3% 8.7% 10.3%
Other 0.0% 0.0% 0.0% 0.0% 0.2% 0.0% 0.1% 0.1%
Unknown 0.0% 1.0% 0.0% 0.3% 0.0% 0.3% 0.1% 0.1%
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Discharges after 4 months - 1 year (full care nursing home)
Men Women
Status Hip fr. Other fr. Post hip fr. Total Hip fr. Other fr. Post hip fr. Total
Died 28 13 35 76 71 64 118 253
Home 25 42 35 102 114 162 271 547
Day care 4 4 9 17 8 6 26 40
Hosp 4 2 7 13 4 8 22 34
Nursing home 1 1 4 6 10 8 11 29
Home for the elderly 15 6 26 47 90 104 162 356
Other 1 1
Unknown 2 1 3
Total 77 68 116 261 299 352 612 1263
Discharges after 4 months - 1 year (percentages - full care nursing home)
Men Women
Status Hip fr. Other fr. Post hip fr. Total Hip fr. Other fr. Post hip fr. Total
Died 36.4% 19.1% 30.2% 29.1% 23.7% 18.2% 19.3% 20.0%
Home 32.5% 61.8% 30.2% 39.1% 38.1% 46.0% 44.3% 43.3%
Day care 5.2% 5.9% 7.8% 6.5% 2.7% 1.7% 4.2% 3.2%
Hosp 5.2% 2.9% 6.0% 5.0% 1.3% 2.3% 3.6% 2.7%
Nursing home 1.3% 1.5% 3.4% 2.3% 3.3% 2.3% 1.8% 2.3%
Home for the elderly 19.5% 8.8% 22.4% 18.0% 30.1% 29.5% 26.5% 28.2%
Other 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.2% 0.1%
Unknown 0.0% 0.0% 0.0% 0.0% 0.7% 0.0% 0.2% 0.2%
Discharges after  > 1 year (full care nursing home)
Men Women
Status Hip fr. Other fr. Post hip fr. Total Hip fr. Other fr. Post hip fr. Total
Died 35 28 64 127 171 117 267 555
Home 3 4 4 11 3 8 9 20
Day care 1 1 2 0
Hosp 1 3 4 7 6 11 24
Nursing home 0 2 2 7 4 6 17
Home for the elderly 3 4 2 9 14 18 18 50
Other 0 0
Unknown 1 1 0
Total 43 37 76 156 202 153 311 666
Discharges after  > 1 year (percentages - full care nursing home)
Men Women
Status Hip fr. Other fr. Post hip fr. Total Hip fr. Other fr. Post hip fr. Total
Died 81.4% 75.7% 84.2% 81.4% 84.7% 76.5% 85.9% 83.3%
Home 7.0% 10.8% 5.3% 7.1% 1.5% 5.2% 2.9% 3.0%
Day care 0.0% 2.7% 1.3% 1.3% 0.0% 0.0% 0.0% 0.0%
Hosp 2.3% 0.0% 3.9% 2.6% 3.5% 3.9% 3.5% 3.6%
Nursing home 0.0% 0.0% 2.6% 1.3% 3.5% 2.6% 1.9% 2.6%
Home for the elderly 7.0% 10.8% 2.6% 5.8% 6.9% 11.8% 5.8% 7.5%
Other 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Unknown 2.3% 0.0% 0.0% 0.6% 0.0% 0.0% 0.0% 0.0%
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Age and sex specific number of nursing home days
Here we assume that the total number of nursing home days can be estimated by including all registered
nursing home days and applying the 1.08 correction coefficient for the nursing homes that were not
registered.
Corrected number of nursing home days for men (full care nursing home)
Hip fracture Other fracture Status post hip fracture
Age
class
1-3
Mo
4-12
Mo
>1 year Total 1-3
Mo
4-12
Mo
>1 year Total 1-3
Mo
4-12
Mo
>1 year Total
0-49 178 123 399 700 2253 1913 691 4857 402 0 1155 1556
50-54 118 210 0 327 257 225 6312 6793 105 138 0 243
55-59 117 318 8252 8686 383 1048 436 1867 384 302 0 687
60-64 159 265 0 423 478 648 0 1126 699 400 0 1098
65-69 488 808 433 1729 804 588 775 2166 1018 2177 4929 8125
70-74 870 819 3618 5307 744 657 17301 18701 2257 2610 14386 19253
75-79 1109 3167 13209 17485 1242 2382 1450 5075 2394 3078 14210 19682
80-84 1536 3840 16011 21387 1105 3110 11789 16005 3198 4407 18642 26247
≥85 1673 4268 22019 27960 1703 2289 11119 15110 3201 7753 28784 39739
Total 6248 13816 63941 84006 8969 12858 49873 71701 13659 20867 82105 116630
Corrected number of nursing home days for women (full care nursing home)
Hip fracture Other fracture Status post hip fracture
Age
class
1-3
Mo
4-12
Mo
>1 year Total 1-3
Mo
4-12
Mo
>1 year Total 1-3
Mo
4-12
Mo
>1 year Total
0-49 91 253 0 343 1004 805 0 1809 484 609 407 1500
50-54 53 0 0 53 387 828 0 1215 348 204 0 552
55-59 96 468 0 564 492 923 0 1416 950 740 970 2660
60-64 297 430 1241 1968 1143 2131 7667 10940 2739 2432 1732 6903
65-69 1385 1011 4103 6498 2885 3729 1783 8397 5800 3684 4801 14284
70-74 3373 5256 12923 21552 3734 6917 12369 23020 11758 9687 23872 45317
75-79 5307 10205 36988 52500 6803 10882 37648 55333 17551 21449 57036 96036
80-84 6687 15867 94698 117252 7158 16093 43242 66493 18835 30015 148240 197090
≥85 9199 22387 118526 150112 7384 20277 87482 115143 19037 37979 186786 243802
Total 26488 55877 268478 350843 30990 62586 190191 283767 77502 106799 423844 608145
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Day care
Number of discharges from day care in 1993 with admission diagnosis
Admission diagnosis Men Women Total
Hip fracture 24 82 106
Other fractures 16 47 63
Status after hip fracture 50 178 228
Total 90 307 397
Proportion of fracture patients vs. total population in day care
When looking at the total population of people in day care, the proportion of people with admission
diagnose of fracture again seems to be relatively stable. Two cross-sectional views are compared; one
from our data analysis, the other from published data.
Cross-sectional situation on 31 December 1993 (our analysis)
Total population Fractures
Age class Men Women Men Women
0-44 56 57 2 0
45-54 111 102 3 2
55-64 365 251 3 5
65-74 1045 888 18 37
75-84 1257 1662 35 66
>=85 345 781 10 32
Total 3179 3741 71 142
6920 213
Percentage of total 2.2% 3.8%
population 3.1%
Cross-sectional situation on 30 September 1992 (published data)
Admission diagnosis Total Proportion of
total population
Proportion of
all fractures
Hip fracture 42 0.6% 20.8%
Other fractures 32 0.5% 15.8%
Status after hip fracture 128 1.9% 63.4%
All fractures 202 3.0% 100.0%
Hip fracture and status after 170 2.5% 84.2%
Total population 6682 100.0%
From those data we conclude that fractures account for about 3.1 % of the population of day care.
About 85 % of these fractures are hip fractures and its sequelae.
Applying the multiplication factor (1.12) described above, it is estimated that in 1993, respectively 239
persons (213*1.12) , and 201 (213*1.12*84.2 %) have been treated daily in day care for respectively
fractures or hip-fractures and its sequelae.
Age and sex specific length of stay (days)
The average length of stay is 201 (SD=416) for men and 151 (SD=215) for women (p=0.27). Median
LOS is 86 days for men and 97 days for women. The high averages combined with a high standard
deviation (especially in men), are explained by the relatively large group of people that stay long in day
care.
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Number of patients by length of stay and admission diagnosis (day care)
0-3 months 4 months -
1 year
> 1 year Total
Men 45 36 9 90
Women 144 138 25 307
Total 189 174 34 397
Length of stay in first year (day care)
Number of months
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Age and sex specific number of day care days
We estimate the total number of day care days on the basis of the registered nursing home days and by
applying the 1.12 correction coefficient for the nursing homes that were not registered.
Corrected number of day care days for men (day care)
Hip fracture Other fracture Status post hip fracture
Age
class
1-3
Mo
4-12
Mo
>1 year Total 1-3
Mo
4-12
Mo
>1 year Total 1-3
Mo
4-12
Mo
>1 year Total
0-49 80 80 56 56
50-54 19 19
55-59 36 36
60-64 246 246 197 1472 1669
65-69 161 161 43 43 116 146 6128 6390
70-74 76 853 930 164 164 103 1191 1294
75-79 78 472 550 157 300 1468 1925 234 1934 456 2624
80-84 123 429 741 1294 48 48 304 479 783
≥85 161 105 257 47 45 205 690 768 1604
Total 600 2106 741 3438 573 300 1468 2340 1037 4637 8823 14438
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Corrected number of day care days for women (day care)
Hip fracture Other fracture Status post hip fracture
Age
class
1-3
Mo
4-12
Mo
>1 year Total 1-3
Mo
4-12
Mo
>1 year Total 1-3
Mo
4-12
Mo
>1 year Total
0-49 308 308
50-54 159 159
55-59 73 73 27 151 178
60-64 307 307 457 1159 1616 131 890 1021
65-69 224 893 1117 146 691 3511 4348
70-74 109 1468 3249 4826 198 365 418 981 909 1432 2342
75-79 309 625 911 1845 460 2043 653 3156 840 4351 2140 7332
80-84 545 2262 684 3492 143 1173 1316 1095 2549 3464 7109
≥85 599 2126 627 3232 188 707 904 1734 727 3152 1303 4996
Total 1786 7681 5471 14819 1063 5052 3134 9185 3875 13376 10418 27485
Outpatient care
Outpatient care is not systematically registered in the Netherlands. For General Practitioners, there are a
series of surveys, but those deal primarily with the typical GP pathology and they allow no estimate of
fracture- or osteoporosis-related number of contacts. For the assessment of the direct cost of outpatient
care, we use published cost estimates.
Home health care
The number of clients of home health care and the number of contacts is estimated on the basis of data
available for the Rotterdam district. No specific information is available on clinical indication for home
health care. To estimate the maximum possible home health care consumption for hip fractures in the
Netherlands, we take the number of patients that go home after discharge from hospital. Next we
assume that they all need home health care. We conclude that at the maximum about 5 % of the total
home health care can be allocated to hip fractures.
Estimate of the maximum use of home health care after hip fracture in the Netherlands
Age
class
Nbr of clients in
home health care
Nbr of
contacts
Nbr of hip
fractures
 Proportion Returning home
after hip fracture.
Proportion
60-64 12715 452584 586 4.6% 494 3.9%
65-69 20788 823545 1007 4.8% 791 3.8%
70-74 29699 1151326 1719 5.8% 1268 4.3%
75-79 34587 1501128 2499 7.2% 1560 4.5%
80-110 74612 1236997 8001 10.7% 3935 5.3%
Total 172401 5165580 13812 8.0% 8048 4.7%
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4.3. Proportionate mortality
Total mortality, all cause by age and sex in the Netherlands
Absolute numbers (1992)5
Age class Men Women Total
0-44 4630 2805 7435
45-54 3736 2362 6098
55-64 8231 4526 12757
65-74 17132 10102 27234
75-84 20899 20384 41283
≥85 11636 23444 35080
Total 66264 63623 129887
Age specific mortality (mortality/1000)
Age class Men Women Total
0-44 0.91 0.58 0.75
45-54 3.82 2.52 3.18
55-64 11.79 6.26 8.97
65-74 33.88 15.89 23.86
75-84 88.76 49.13 63.48
≥85 224.74 165.08 181.02
Total 8.79 8.26 8.52
Osteoporosis mortality by age and sex
Osteoporosis related mortality is due to fractures, mainly hip fractures. Mortality following hip fractures
is high and age dependent.15 Attributing death to fractures however is not easy. Hip fractures may be
associated with death in various ways and official death certification does not necessarily reflect the
underlying cause. Therefore, it is felt that official death certification is in no way sufficient to indicate
the real death toll of osteoporosis. Excess mortality after hip fracture needs to be looked upon. In
addition of the official death certification data, mortality data from a follow-up study in the Netherlands
(Utrecht) are included.
Official death certification data for 1993 with death due to an external cause associated with hip-
fracture (and a few death with primary cause osteoporosis).
Men and women
Primary cause of death 0-44 45-54 55-64 65-74 75-84 ≥85 Total
E826 Pedal cycle accident 1 1
E880 Fall on stairs or steps 1 1
E884 Other falls one level to other 1 4 5
E885 Fall on level-tripping 4 6 10
E887 Fracture, cause unspecified 33 244 563 840
E888 Fall unspecified /unclassifiable 1 5 26 45 77
Total external causes of death 1 1 40 275 618 934
7330 Osteoporosis 1 1 10 14 26
Grand Total 2 1 41 285 632 960
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Men
Primary cause of death 0-44 45-54 55-64 65-74 75-84 ≥85 Total
E826 Pedal cycle accident 1 1
E884 Other falls one level to other 2 2
E885 Fall on level-tripping 2 3 5
E887 Fracture, cause unspecified 16 91 136 243
E888 Fall unspecified /unclassifiable 1 3 9 17 30
Total external causes of death 1 20 102 158 281
7330 Osteoporosis 4 3 7
Grand Total 1 20 106 161 288
Women
Primary cause of death 0-44 45-54 55-64 65-74 75-84 ≥85 Total
E880 Fall on stairs or steps 1 1
E884 Other falls one level to other 1 2 3
E885 Fall on level-tripping 2 3 5
E887 Fracture, cause unspecified 17 153 427 597
E888 Fall unspecified /unclassifiable 2 17 28 47
Total external causes of death 1 20 173 460 653
7330 Osteoporosis 1 1 6 11 19
Grand Total 2 21 179 471 672
Those numbers need to be interpreted with great care. As said before, they do not reflect the increased
mortality after hip fracture. In fact, combined with the number of hip fractures in the Netherlands, they
show lower mortality rates after hip fracture than in the population at large. Therefore, those data are
insufficient to describe mortality associated with hip fractures.
Dutch follow-up data on mortality after hip fracture
In our data, we observe an overall in-hospital mortality of 10.1 % for men and 5.9 % for women. This
in-hospital mortality is strongly age dependent, rising from almost non-existent at younger ages to 22%
for men and 10 % for women in the highest age group. Mortality in men is twice as high as in women
for all age groups.
In-hospital mortality after hip fracture (observed values in 5 year age classes, and calculated
regression curves)
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We cannot correctly assess mortality after hospitalisation from our data, although we do present some
information on mortality in nursing homes. For a better idea of the mortality after hip fracture, we need
follow-up data. Boereboom et al. studied 493 patients with a hip fracture during the period 1982-1984
in three hospitals in Utrecht.16 In-hospital mortality was similar to our findings with 9.1 % of the
patients dying during hospitalisation. One year after the hip fracture, 23.6 % of the women and 33 % of
the men had died.
Mortality was highest during the first 8 weeks after the hip fracture and strongly age and sex dependent.
Relative risk of dying for men was 1.88 (95% CI 1.40-2.53) compared to women. Concomitant illness
and hospital complications were also shown to be related with mortality. When looking at the official
cause of death mentioned on the death certificate, it was found that in only 19 % of the women and 25
% of the men, hip fracture was mentioned as cause of death.
Mortality after hip fracture is strongly elevated in the months following the event, especially in men.
One should be careful however not to attribute all of this excess mortality exclusively to the hip
fractures. Patients with a hip fracture more often have concomitant illnesses and a poor general
condition. This condition in itself can increase the risk of falling and the perioperative risk. This
condition can also impair the rehabilitation after the treatment and hamper the mobilisation.
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4.4. Assessment of direct medical cost for osteoporosis and fractures
To assess the medical cost of osteoporosis and fractures, we use two separate approaches. In the first
(global approach) we use published Dutch cost estimates for hip, forearm and vertebral fractures. Those
estimates are combined with our incidence figures. In a second approach, the detailed costs of medical
consumption related to osteoporosis and fractures are calculated, based on the medical consumption
described in this report.
Global approach
In a 1993 iMTA report, Al et al. estimate the cost of hip, vertebral and forearm fractures.17 Costs for
hospital treatment, complications, home care, physiotherapy and GP visits are estimated. Nursing home
care was not included in this iMTA estimate, since it was argued that the fracture very often is but the
trigger, rather than the cause of the entrance into a nursing home. The demand for home health care was
used as a proxy for the additional help needed. For vertebral fractures, we use the cost for clinically
diagnosed fractures, since the incidence figures only reflect this category of vertebral fractures.
Costs for fractures
Hip fracture ƒ 22919
Vertebral fracture ƒ 2295
Forearm fracture ƒ 1859
We apply those costs to the (partly estimated) 1993 incidence figures for the Netherlands. For this part
of the analysis, we consider only fractures at the age of 50 and older, the age of 50 being an arbitrary
cut-off point for osteoporotic fractures.
Hip fractures (million ƒ)
Age class Men Women Total
50-54 2.29 2.82 5.11
55-59 3.41 4.40 7.82
60-64 4.63 8.80 13.43
65-69 7.01 16.07 23.08
70-74 10.73 28.67 39.40
75-79 14.76 42.52 57.28
80-84 15.65 57.83 73.48
≥85 19.05 90.85 109.90
Total 77.54 251.95 329.49
Vertebral fractures (million ƒ)
Age class Men Women Total
50-54 0.57 1.15 1.72
55-59 0.69 2.08 2.77
60-64 0.31 2.33 2.64
65-69 0.93 3.59 4.52
70-74 0.79 4.34 5.13
75-79 1.59 5.15 6.74
80-84 0.84 4.95 5.78
≥85 1.58 3.95 5.53
Total 7.30 27.53 34.83
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Forearm fractures (million ƒ)
Age class Men Women Total
50-54 0.93 2.69 3.62
55-59 0.63 3.36 3.99
60-64 0.46 4.26 4.72
65-69 0.60 3.56 4.16
70-74 0.37 3.71 4.09
75-79 0.31 2.30 2.61
80-84 0.13 1.72 1.85
≥85 0.08 1.85 1.92
Total 3.50 23.46 26.96
Global estimated costs for hip, vertebral and forearm fractures (million ƒ)
Hip fracture 329.49
Vertebral fracture 34.83
Forearm fracture 26.96
Total 391.28
Global age-specific estimated costs for hip, vertebral and forearm fractures (million ƒ)
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Detailed approach
In this detailed approach, the analysis is again limited to persons 50 years of age and older. It is clear
that not all of those fractures are osteoporosis related, and that even those that are, can not all be
prevented. The next section gives an overview of total cost; the preventable cost will evidently depend
on the effectiveness of the proposed preventive measures.
The choice of the costs corresponding with one day of hospitalisation, one contact, etc. are based on the
Dutch guidelines for cost calculations in health care.18 The costs per person-year of pharmacotherapy
are calculated based on cost information in the Pharmacotherapeutisch kompas 19 and on the
recommended dosage.
Pharmacotherapy
1993 person years
(x1000)
Price (ƒ) per
person year
1993 total cost
(million ƒ)
Didrokit 18.6 543.2 10.11
Calcium Forte 11.7 173.2 2.03
Calcium
Fortissimum
5.8 169.3 0.98
Cacit 500 5.0 173.2 0.87
Etalpha 0.9 559.9 0.51
Didronel 0.2 414.7 0.08
Progynova 1.2 164.8 0.20
Decadurabolin 0.4 203.9 0.09
Devaron 5.3 32.9 0.18
Premarin 0.3 259.8 0.08
Procal 0.5 19.7 0.01
Zumenon 0.2 195.4 0.03
Estraderm TTS 1.3 242.2 0.32
Dohyfral AD3 9.1 16.2 0.15
Total 60.6 15.63
Hospitalisations for hip fractures
To assess the direct cost of hip fracture hospitalisation, the number of hospitalisation days for persons
over age 50, are combined with an average daily price for hospitalisation of ƒ 773.
Direct cost of hip fracture hospitalisation (million ƒ)
Age class Men Women Total cost
50-54 1.25 1.52 2.77
55-59 2.03 2.85 4.88
60-64 2.91 5.50 8.40
65-69 4.65 11.81 16.46
70-74 8.46 21.90 30.35
75-79 13.2 37.87 51.07
80-84 14.88 57.92 72.80
≥85 17.63 90.43 108.06
Total 65.01 229.79 294.80
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Hospitalisations for non-hip fractures
Hospitalisation for non-hip fractures can be estimated from 1992 figures. We only have the proportion
of persons aged 65 and older. This means we disregard the patients aged between 50 and 64 which
probably leads to an underestimation. On the other hand, those fractures will also include non-
osteoporosis related fractures, leading to an overestimation.
For the reasons mentioned in the corresponding chapter, it is unclear whether or not those figures
should be included in an estimate of the cost of osteoporosis. We include them here for the sake of
completeness in the maximum cost estimate.
Average length of stay in 1992 was 5.7 for forearm fractures and 17.2 for vertebral fractures.11
Direct cost of non-hip hospitalisations (patients ≥65 years) in 1992
Total ≥65 years days Total cost
Vertebrae 2586 977 16804 12.99
Forearm 4180 902 5141 3.97
Total 6766 1879 21945 16.96
Non-hospital inpatient care (full care)
It would be an overestimation to include all nursing home patient days. Fracture can be the trigger that
changes a borderline independent state into a dependent state of life, for people who would anyhow
arrive in a nursing home. As argued in the chapter on nursing homes, we only consider the first three
months of stay in a nursing home, in the calculation of the cost. It should be clear that using the cut-off
point of 3 months is an arbitrary choice, but a choice that is based upon the arguments developed in the
discussion on length of stay and discharge status.
An average daily price for nursing home care of ƒ 209 is used.
Direct cost of nursing home care for fractures (million ƒ)
Men Women Total cost Grand Total
Age class
Hip
fr.
Other
fr.
Post
hip fr.
Hip
fr.
Other
fr.
Post
hip fr.
Hip
fr.
Other
fr.
Post
hip fr.
All fractures
50-54 0.07 0.12 0.04 0.01 0.18 0.11 0.08 0.30 0.16 0.53
55-59 0.09 0.20 0.12 0.06 0.19 0.32 0.15 0.39 0.44 0.98
60-64 0.05 0.16 0.19 0.14 0.57 0.88 0.20 0.73 1.07 2.00
65-69 0.23 0.25 0.50 0.52 1.12 1.79 0.74 1.37 2.29 4.40
70-74 0.33 0.42 0.95 1.45 1.83 3.92 1.77 2.25 4.87 8.89
75-79 0.75 0.51 1.14 2.82 3.19 7.05 3.57 3.70 8.19 15.46
80-84 1.02 0.83 1.55 4.39 4.22 9.42 5.41 5.05 10.97 21.43
≥85 1.17 0.81 2.21 6.42 5.29 11.50 7.59 6.10 13.72 27.41
Total 3.70 3.30 6.71 15.80 16.59 35.00 19.50 19.89 41.70 81.10
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Non-hospital inpatient care (day care)
For the same reason as with the nursing homes, only the first 3 months of day care are included in the
calculation of the cost. An average daily price for day care of ƒ 122 is used.
Direct cost of day care for fractures (million ƒ)
Men Women Total Grand Total
Age class
Hip
fr.
Other
fr.
Post
hip fr.
Hip
fr.
Other
fr.
Post
hip fr.
Hip
fr.
Other
fr.
Post
hip fr.
All fractures
50-54 0.000 0.000 0.002 0.000 0.000 0.012 0.000 0.000 0.015 0.015
55-59 0.000 0.004 0.000 0.000 0.009 0.016 0.000 0.013 0.016 0.029
60-64 0.012 0.000 0.037 0.025 0.037 0.066 0.037 0.037 0.103 0.178
65-69 0.020 0.005 0.064 0.065 0.000 0.105 0.084 0.005 0.169 0.259
70-74 0.059 0.020 0.087 0.138 0.062 0.223 0.197 0.082 0.311 0.589
75-79 0.047 0.057 0.166 0.113 0.181 0.389 0.160 0.237 0.555 0.952
80-84 0.052 0.006 0.074 0.216 0.080 0.408 0.269 0.086 0.483 0.837
≥85 0.032 0.006 0.062 0.248 0.098 0.351 0.280 0.104 0.413 0.797
Total 0.223 0.098 0.494 0.804 0.467 1.571 1.027 0.564 2.065 3.656
Outpatient care
No hard data on the outpatient care for osteoporosis related fractures are available for the Netherlands.
In the absence of those data we use the assumptions for outpatient care from Al et al.17 that are also
used in the global approach.
For hip fractures, they assume that patients have on the average 2 GP visits after the discharge from
hospital and that 50 % of the patients have an average of 12 treatment sessions by a physiotherapist.
This leads to a global outpatient care price of ƒ 319 per hip fracture.
For vertebral fractures, they assume that 5 out of 6 of the total number of clinically diagnosed patients
are treated by the GP. 5 GP visits, one specialist visit (including an X ray) and 12 treatment sessions by
a physiotherapist are assumed with a total cost of ƒ 1204, leading to an outpatient cost of ƒ 1003 per
vertebral fracture.
For forearm fractures, they assume that 95 % of patients are treated in the outpatient clinic with a total
cost of ƒ 1658. This lead to a cost per forearm fracture of ƒ 1575.
Although those assumptions are arbitrary, they are thought to give a good approximation of the mean
cost of the outpatient consumption. Furthermore, a sensitivity analysis showed that the impact of the
outpatient care uncertainty on the total cost is limited.
Taking the same incidence figures as in the global approach, this leads to the following cost.
Global estimated costs for outpatient care for hip, vertebral and forearm fractures (million ƒ)
Hip fracture 4.59
Vertebral fracture 15.23
Forearm fracture 22.84
Total 42.66
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Home health care
Based on the assumptions made in the chapter on Home health care, we can calculate maximum
possible cost for home health care related to hip fractures. In order to do so, we use a price of ƒ 55 per
contact.
Estimated maximum possible cost for home health care after hip fracture (million ƒ)
Nbr of
contacts
Max % Maximum nbr. of hip
fract. related contacts
Cost
60-64 452584 3.9% 17584 0.97
65-69 823545 3.8% 31337 1.72
70-74 1151326 4.3% 49156 2.70
75-79 1501128 4.5% 67706 3.72
80-110 1236997 5.3% 65239 3.59
Total 5165580 231021 12.71
Overview of the detailed approach
Detailed overview of costs for osteoporosis treatment in the Netherlands in 1993 (million ƒ)
Estimated yearly cost
Pharmacotherapy 15.63
Hospitalisations hip fractures 294.80
Non-hospital inpatient care (full care) 81.10
Day care 3.66
Outpatient care 42.66
Total (excluding maximum estimates) 437.85
Hospitalisations non-hip fractures (max. est.) 16.96
Home health care (maximum estimate) 12.71
Total (including maximum estimates) 467.52
5. Conclusions
Prevalence and incidence
Osteoporosis and fractures are a major source of illness and health care costs in the Netherlands, both
today as in the foreseeable future. Especially the most serious consequence, hip fracture, is frequent and
the incidence is increasing. Both in men and women, the incidence increases exponentially with age.
Men reach the same hip fracture incidence at an age 5-6 year older than women. An 80-year-old male
has the same hip fracture risk as a 75-year-old female.
The total number of hip fractures will inevitable rise if no serious prevention efforts are undertaken. An
upward time trend in age-adjusted hip fracture rates, as well as the ageing of the population are
responsible for this. Several possible explanations for the upward trend have been suggested, such as
the decreasing physical activity and sedentary live style, nutrition, or even the fact that people are
growing taller than before. In the US, Sweden, and the UK, this upward trend of age-adjusted hip
fractures seems to have levelled off.13 In other places such as Hong Kong and, as we show, also in the
Netherlands, the rates are still increasing. While it is difficult to predict the evolution of this trend in
this country, the ageing of the population is sure. Even when current incidence rates remain stable in the
future, the total number of hip fractures will double by the year 2050 to over 30.000 per year.
Non-hip fracture incidence rates are more difficult to obtain and we derive them from international data.
But, since we focus on cost and personal illness burden, non-hip fractures appear to be less relevant.
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Prevention
For the prevention of osteoporotic fractures it is important to know who are at risk as well as which
preventive strategy is effective for the different risk categories. The parameter that is most commonly
used nowadays to determine fracture risk is bone mineral density (BMD). Cummings et al. found an
age-adjusted relative risk for hip fracture of 2.6 per SD decrease in femoral neck bone density.3 Bone
density at the hip is also more strongly related to the risk of hip fracture than bone density measured at
other sites.  A limitation of the follow-up studies carried out until today is the short follow-up time.
The observed and relatively modest decline in bone density with age can however not fully explain the
exponential increase of hip fracture incidence with age. This suggests that also other factors are
important contributors to the fracture risk, namely the previously mentioned bone quality and the
propensity to fall.
Prevention only focussed on bone mineral density will thus do nothing to prevent the hip fractures
caused by the above mentioned factors. An additional effect of therapy on bone quality can be
important and the intervention should certainly not have adverse effects on bone quality, as suggested in
some studies of high-dose sodium fluoride.20
The cost-effectiveness of interventions is further influenced by other effects apart from the effect on
bone strength, such as in the oestrogen supplementation scenarios. In a recent report from the Study of
Osteoporotic Fractures Research Group, its authors conclude that estrogen prevents fractures not only
by preserving bone mass but also by other additional mechanisms.21 Effects on muscle strength and
neuromuscular function have been suggested, as well as effects on co-morbidity and cardiovascular
function, but this is still under debate.22,23,24
Reducing the frequency and severity of falls, and the use of external protective devices, together with
physical exercise and other lifestyle interventions, have also been looked at as additional intervention
possibilities.
Another problem of intervention solely focused on bone mineral density is the timing. Hip fractures
incidence only rises above 1 % after the age of 80 for women and 85 for men. When the moment of
intervention is at or soon after the menopause, we can expect that even with effective therapeutic
strategies, the compliance with medication will be poor. If possible, it would be preferable to bring the
preventive intervention nearer to the adverse outcome.
Mortality
Although hip fractures occur less frequently in men, their mortality after a hip fracture is more
important. We found an in-hospital mortality that is twice that of women. Mortality is also strongly age
dependent and related to concomitant illnesses and in-hospital complications. Published follow-up data
show that mortality after hip fracture is strongly elevated in the first few months following the event, but
the available data for the Netherlands do not allow a more precise estimate of the duration of the excess
mortality.
One should be careful not to attribute exclusively all of this excess mortality to hip fractures. Patients
with a hip fracture more often have concomitant illnesses and a poor general condition. This condition
in itself can increase the risk of falling and the perioperative risk. This situation can also impair the
rehabilitation after treatment and hamper mobilisation.
Health care utilisation
Osteoporosis and fractures are an important cause of health care consumption. Hip fractures as a rule
lead to long hospitalisation with a mean length of stay of 26 days. Forearm and vertebral fractures are
most frequently treated in an outpatient setting. People over age 85, representing less than 2 % of the
population nevertheless cause over one third of the hospitalisation days for hip fractures. This is due
both to the exponential increase of hip fracture with age, and to the longer length of stay. With an
ageing population this will only deteriorate.
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After the acute phase and the hospitalisation, nursing home care is often needed. Using hospital data,
we see that 21 % of men and 27 % of women are discharged directly into nursing homes. This
difference can partly be explained by the higher in-hospital mortality of men. In the nursing home data
we see a similar number of men being admitted, but there are more women entering (about 33 % of the
hip fractures). Apparently, some of the women return to their homes first, but are afterwards transferred
to a nursing home. Nursing home stays can be very long, but the majority of patients leave the nursing
home within 3 months. We presume that stays longer than 3 months are not related anymore to the hip
fracture that leads to the admission. We use the same approach dealing with day care cost.
Other health care consumptions are home health care and outpatient care. Hard data about those
activities are scarce and we make an attempt to estimate them using indirect information. Their
contribution to the total cost of osteoporosis is substantial but secondary to hospital and nursing home
cost. Drug use is also relatively unimportant for the total cost.
Cost
In this study we estimate the direct cost associated with fractures at older age. The majority of these
fractures are osteoporosis related, but not all. A clear indication of the fact that most of these fractures
are osteoporosis related is found in the observation that incidence increases exponentially with age. It is
not possible to differentiate between osteoporotic fractures and non-osteoporotic fractures but we
believe that the impact of the latter category is small.
The cost of osteoporosis is mainly the cost of hip fractures. It is this cost we could determine most
accurately. In comparison, the cost of other fractures and the current cost of pharmacotherapy is low.
We use two approaches to come to a global yearly cost of osteoporosis and fractures in the population
aged 50 and over. The results of both the global and the detailed approach are comparable, and indicate
a yearly cost between ƒ 390 and ƒ 470 million. The main difference between both approaches lies in the
cost of nursing home care (non-hospital inpatient care). Nursing home care is not included in the global
approach. In the detailed approach, we assume that only the first three months of nursing home care
should be attributed to the fracture, the remainder being due to co-morbidity and frailty.
The medication cost of osteoporosis is difficult to ascertain, and the validity of the IMS data is not
clear. It is however the only currently available source. It appears that the cost of medication is minor,
compared to the cost of clinical treatment of the fractures.
We do not include indirect costs as osteoporosis mainly affects the elderly and their production losses
can be neglected.
When comparing this cost with international figures, we find both higher and lower estimates.13
Several studies indicate a cost of US$ 7 - 10 billion for the United States resulting in a yearly cost per
capita of ƒ 50 - 70 for osteoporosis and hip fractures. Our maximum global cost estimate of ƒ 457
million is the equivalent of ƒ 30 per head of the population. The US estimates however do include the
indirect costs that we choose not to include. The estimates for France are lower, with a global cost of
FF 3.5 billion and a per capita cost of ƒ 20.
Further research
For this report, no primary data collection was done. Therefore, some of the fundamental questions will
remain open, without additional research being done.
The bone mineral density data in this report are cross-sectional. Currently there are no prospective data
about the predictive value of BMD measurements in the Netherlands. The Rotterdam study will, over
time, provide these follow-up data on BMD evolution and fractures.
Osteoporosis is influenced by various risk factors, and it progresses silently for decades before fractures
occur. Bone density can be measured directly, whereas other risk factors are measured by using age as a
proxy. In general there are  no symptoms prior to the fracture, making osteoporosis difficult to diagnose
before an event occurs. In order to prevent them, we need to know who is most likely to experience a
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major fracture and when this is most likely to occur. An additional problem is the fact that eventually all
people are at high risk  given they live long enough.
Clinical trials should not only focus on an intermediate outcome such as BMD, but must be designed to
show the effect on the final outcome, even though this approach is limited by the long follow-up times
needed. Current guidelines for clinical trials require evidence about the effect on bone density. In
addition they also demand that there is no indication of detrimental effect on bone architecture or
strength and that there is evidence for decreased fracture risk after at least three years.25
In this report we assume that fractures at an older age are due to osteoporosis, and that they in turn have
an impact on mortality, morbidity, and the quality of life. More research is needed to clarify this chain
of events in order to evaluate whether prevention of osteoporosis and fractures will also influence those
aspects of the disease. Only a better insight into this chain of events can lead to a proper cost-
effectiveness analysis of suggested prevention strategies.
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